- Home
- ALVO vs MMI Comparison
ALVO vs MMI Comparison
Compare ALVO & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALVO | MMI |
|---|---|---|
| Founded | 2013 | 1971 |
| Country | Luxembourg | United States |
| Employees | N/A | 854 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ALVO | MMI |
|---|---|---|
| Price | $4.60 | $27.60 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.80 | N/A |
| AVG Volume (30 Days) | ★ 992.5K | 146.0K |
| Earning Date | 11-11-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 1.77% |
| EPS Growth | N/A | ★ 84.38 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $719,700,000.00 |
| Revenue This Year | $11.96 | $11.37 |
| Revenue Next Year | $17.65 | $11.14 |
| P/E Ratio | ★ $18.20 | $1,418.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.94 | $24.43 |
| 52 Week High | $8.50 | $33.55 |
Technical Indicators
Market Signals| Indicator | ALVO | MMI |
|---|---|---|
| Relative Strength Index (RSI) | 34.10 | 40.40 |
| Support Level | $3.10 | $26.96 |
| Resistance Level | $4.59 | $28.80 |
| Average True Range (ATR) | 0.27 | 0.66 |
| MACD | -0.13 | 0.08 |
| Stochastic Oscillator | 1.25 | 37.25 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans. The Company has one reportable segment: commercial real estate services. The commercial real estate services segment is the aggregation of our two operating segments: investment sales and financing services.